{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20011116",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "42109",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-341_Bextra.html",
              "date": "20020530",
              "type": "Review"
            },
            {
              "id": "15219",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21341lbl.pdf",
              "date": "20011116",
              "type": "Label"
            },
            {
              "id": "23646",
              "url": "http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103420.htm",
              "date": "20031209",
              "type": "Other Important Information from FDA"
            },
            {
              "id": "27517",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-341_Bextra_Approv.pdf",
              "date": "20011116",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20041124",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "27519",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21341ltr.pdf",
              "date": "20041202",
              "type": "Letter"
            },
            {
              "id": "36691",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21341lbl.pdf",
              "date": "20041203",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20021101",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "42110",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021341_S002_BEXTRATOC.cfml",
              "date": "20070110",
              "type": "Review"
            },
            {
              "id": "5084",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21341slr002ltr.pdf",
              "date": "20021101",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20040423",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "27518",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21341se8-003ltr.pdf",
              "date": "20040429",
              "type": "Letter"
            },
            {
              "id": "36690",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21341se8-003_bextra_lbl.pdf",
              "date": "20040504",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA021341",
      "sponsor_name": "GD SEARLE",
      "products": [
        {
          "product_number": "003",
          "reference_drug": "No",
          "brand_name": "BEXTRA",
          "active_ingredients": [
            {
              "name": "VALDECOXIB",
              "strength": "20MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Discontinued"
        },
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "BEXTRA",
          "active_ingredients": [
            {
              "name": "VALDECOXIB",
              "strength": "10MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Discontinued"
        }
      ]
    }
  ]
}